Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

National Vision Holdings Inc (EYE)

National Vision Holdings Inc (EYE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,919,151
  • Shares Outstanding, K 78,525
  • Annual Sales, $ 1,537 M
  • Annual Income, $ 23,650 K
  • 60-Month Beta 1.44
  • Price/Sales 1.22
  • Price/Cash Flow 16.48
  • Price/Book 2.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.08
  • Number of Estimates 2
  • High Estimate 0.11
  • Low Estimate 0.05
  • Prior Year 0.16
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.02 +8.67%
on 10/08/19
28.16 -15.02%
on 09/17/19
-3.84 (-13.83%)
since 09/16/19
3-Month
22.02 +8.67%
on 10/08/19
32.60 -26.60%
on 08/07/19
-7.51 (-23.89%)
since 07/16/19
52-Week
22.02 +8.67%
on 10/08/19
45.88 -47.84%
on 11/08/18
-18.57 (-43.69%)
since 10/16/18

Most Recent Stories

More News
EYE vs. LMAT: Which Stock Should Value Investors Buy Now?

EYE vs. LMAT: Which Stock Is the Better Value Option?

EYE : 23.93 (-2.09%)
LMAT : 33.93 (+0.50%)
Interesting EYE Put And Call Options For November 15th

Investors in National Vision Holdings Inc saw new options become available this week, for the November 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EYE...

EYE : 23.93 (-2.09%)
GNC Holdings Inks Retail Partnership Deal to Grow in Brazil

We consider this corporate deal in Brazil to be a strategic fit for GNC Holdings (GNC), which currently pulls out all the stops to fortify its global footprint.

GNC : 2.06 (-0.48%)
VLRX : 1.40 (+9.38%)
MYO : 0.63 (+3.28%)
EYE : 23.93 (-2.09%)
Innovation Aids Genomic Health, Merger Procedure on Track

Genomic Health (GHDX) is on course to realize its impending merger with cancer diagnostics major Exact Sciences, which will integrate brands like Cologuard and OncotypeDX.

GHDX : 70.68 (-0.90%)
MYO : 0.63 (+3.28%)
VLRX : 1.40 (+9.38%)
EYE : 23.93 (-2.09%)
National Vision's Store Launches on Track Despite Cost Woes

National Vision (EYE) adopts a formula-based approach to open around 75 stores in 2019.

BAX : 87.02 (-0.82%)
NUVA : 63.70 (+0.11%)
MDT : 108.50 (+0.29%)
EYE : 23.93 (-2.09%)
Neogen Gets AOAC Validation for NeoSeek to Ensure Food Safety

Neogen's (NEOG) proprietary testing platform gets upgraded to reduce the incidence of bacterial contamination in livestock.

CAPR : 2.84 (+10.08%)
LMAT : 33.93 (+0.50%)
NEOG : 65.30 (+0.66%)
EYE : 23.93 (-2.09%)
NuVasive's New TLIF Implant Broadens Spine Surgery Option

NuVasive's (NUVA) Modulus TLIF-A is designed to work smoothly with the existing MAS TLIF and MAS Midline access systems.

CAPR : 2.84 (+10.08%)
LMAT : 33.93 (+0.50%)
NUVA : 63.70 (+0.11%)
EYE : 23.93 (-2.09%)
First Week of April 2020 Options Trading For National Vision Holdings (EYE)

Investors in National Vision Holdings Inc saw new options begin trading this week, for the April 2020 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is...

EYE : 23.93 (-2.09%)
EYE vs. HAE: Which Stock Should Value Investors Buy Now?

EYE vs. HAE: Which Stock Is the Better Value Option?

EYE : 23.93 (-2.09%)
HAE : 125.06 (-1.15%)
Boston Scientific's (BSX) Vercise Gevia DBS Gets FDA Nod

Boston Scientific's (BSX) Vercise Gevia DBS system should boost neuromodulation revenues for the company.

CAPR : 2.84 (+10.08%)
LMAT : 33.93 (+0.50%)
BSX : 38.18 (-0.73%)
EYE : 23.93 (-2.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade EYE with:

Business Summary

National Vision Holdings, Inc. is involved in optical retail primarily in the United States. The company offer product and services for eye care needs through retail stores and consumer websites. Its brand portfolio consists of America's Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside...

See More

Key Turning Points

2nd Resistance Point 24.60
1st Resistance Point 24.27
Last Price 23.93
1st Support Level 23.73
2nd Support Level 23.52

See More

52-Week High 45.88
Fibonacci 61.8% 36.77
Fibonacci 50% 33.95
Fibonacci 38.2% 31.13
Last Price 23.93
52-Week Low 22.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar